SoylentNews is people
SoylentNews is powered by your submissions, so send in your scoop. Only 9 submissions in the queue.
SoylentNews
Submission Preview
Breakthrough Alzheimer's drugs too pricey for UK's National Health Service
From:
https://www.bbc.co.uk/news/articles/cq8zxx9kk0ko [bbc.co.uk]
Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The medicines are the first to slow the disease, which may give people extra time living independently.
The National Institute for Health and Care Excellence (NICE) concluded they were a poor use of taxpayers' money and said funding them could lead to other services being cut. Campaigners say it is a disappointment, but other dementia experts have also supported the decision.
The two drugs, donanemab and lecanemab, both help the body clear a gungy protein that builds up in the brains of people with Alzheimer's disease.
You too can wear a nose mitten.
